AGIOS PHARMACEUTICALS, INC.
AGIOS PHARMACEUTICALS, INC.
CAMBRIDGE, MA
Loading...
Price History
Market Data
| Market Cap | 1.60B |
| P/E Ratio | - |
| P/B Ratio | 1.34 |
| EPS | -7.11 |
| Dividend Yield | - |
| D/E Ratio | 0.09 |
| Current Ratio | 11.46 |
| Currency | USD |
Key Financial Metrics
54.03M
Revenue
-412.78M
Net Income
-7.11
EPS (Diluted)
-679.80M
Free Cash Flow
Profitability
Gross Margin
88.3%
Operating Margin
-873.9%
Net Profit Margin
-764.0%
EBITDA
-472.13M
Returns & Efficiency
Return on Assets (ROA)
-31.8%
Return on Equity (ROE)
-34.6%
Dividend Yield
-
EPS
-7.11
Financial Health
Total Assets
1.30B
Total Debt
-
Debt to Equity
0.09x
Current Ratio
11.46
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | CAMBRIDGE, MA |
| Fiscal Year | 2025 |
Peers
LILLY ELI & CO
LLY
931.26B
P/E: --
ELI LILLY & CO
LLY
931.26B
P/E: --
543.83B
P/E: --
ABBVIE INC.
ABBV
365.53B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
281.00B
P/E: --
MERCK & CO. INC.
MRK
281.00B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$1.60B
P/E Ratio (TTM)-
Price to Book1.34
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin88.3%
Operating Margin-873.9%
Net Margin-764.0%
ROE-34.6%
ROA-31.8%
Leverage & Liquidity
Debt to Equity0.09
Current Ratio11.46
Total Debt-
Total Assets$1.30B
Stockholders' Equity$1.19B
Income Statement (FY 2025)
Revenue$54.03M
Gross Profit$47.68M
Operating Income$-472.13M
Net Income$-412.78M
EPS (Diluted)$-7.11
Cash Flow (FY 2025)
Free Cash Flow$-679.80M
Cash & Equivalents$89.13M
Revenue Growth48.0%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 88 SIDNEY STREET CAMBRIDGE, MA 02139 |
| Phone | 617-649-8600 |
| Incorporated | DE, US |
| EIN | 000000000 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 58.59M |
| Stockholders' Equity | $1.19B |
| Cash & Equivalents | $89.13M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-29
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-29
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-02
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-02
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-02
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-02
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-02
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-04-02
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | AGIOS PHARMACEUTICALS, INC. |
| Ticker | AGIO |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | CAMBRIDGE, MA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 1.60B |
| Revenue | 54.03M |
| Net Income | -412.78M |
| P/E Ratio | - |
| EPS | -7.11 |
| Net Margin | -764.0% |
| ROE | -34.6% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...